Please provide a comprehensive summary of NCCN guidelines for my Lymphoma stage II cancer. What are the standard...

LymphomaOctober 17, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

Please provide a comprehensive summary of NCCN guidelines for my Lymphoma stage II cancer. What are the standard treatment options I should know about?

I'll help you understand the standard treatment options for Stage II Lymphoma, but first, I should note that treatment recommendations can vary based on whether you have Hodgkin or Non-Hodgkin Lymphoma, and the specific subtype. I'll provide information for both main types:

For Hodgkin Lymphoma (Stage II): According to the current NCCN Guidelines:

  • The primary treatment approach is combination chemotherapy with ABVD (Adriamycin, Bleomycin, Vinblastine, Dacarbazine)
  • Typically 2-4 cycles of ABVD, often followed by involved-site radiation therapy (ISRT)
  • For favorable cases, 2 cycles + radiation may be sufficient
  • For unfavorable cases, 4-6 cycles may be recommended

For Non-Hodgkin Lymphoma (Stage II): The Lymphoma Research Foundation and NCCN Guidelines indicate:

  • For B-cell lymphomas (most common type), the standard treatment is R-CHOP chemotherapy (Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone)
  • Usually 3-6 cycles depending on risk factors
  • Radiation therapy may be added after chemotherapy in some cases

According to the American Society of Clinical Oncology (ASCO):

  • Treatment decisions should be individualized based on: • Specific lymphoma subtype • Presence of B symptoms (fever, night sweats, weight loss) • Bulk of disease • Patient age and overall health

Important notes:

  1. This is general guidance - your specific treatment plan may differ based on your individual case
  2. Always consult with your oncologist for personalized treatment recommendations
  3. Clinical trials may be available and worth discussing with your healthcare team

Would you like me to provide more specific information about either Hodgkin or Non-Hodgkin Lymphoma treatment options? Knowing your specific type would help me provide more targeted information from the guidelines.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: